To test if the presence of anti-VEGF antibodies impaired the development of experimental tumors, immunized mice were inoculated with two different syngenic models of highly aggressive renal cell carcinoma (RENCA) and melanoma (B16) cells that produced equivalent amounts of VEGF. The gene discussed is VEGFA; the disease is melanoma.